Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome
Bas W.G. van Rhijn(The Netherlands Cancer Institute), Ellen C. Zwarthoff(Erasmus MC), Theodorus van der Kwast(Erasmus MC), E. C. M. Ooms(Hôpitaux Universitaires Henri-Mondor), André N. Vis(Hôpitaux Universitaires Henri-Mondor), François Radvanyi(Centre National de la Recherche Scientifique), Egbert R. Boevé(Hôpitaux Universitaires Henri-Mondor), Adriaan C. Jöbsis(Hôpitaux Universitaires Henri-Mondor), Wim J. Kirkels(Erasmus MC), Dominique Chopin(Hospices Civils de Lyon)
Cited by 321
Related Papers
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654